Pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C: role of steatosis and body mass index

MeSH terms

• Adult
• Antiviral Agents / adverse effects
• Antiviral Agents / therapeutic use*
• Biopsy
• Body Mass Index*
• Drug Therapy, Combination
• Fatty Liver / diagnosis*
• Female
• Hepatitis C, Chronic / diagnosis
• Hepatitis C, Chronic / drug therapy*
• Hepatitis C, Chronic / surgery
• Humans
• Immunosuppressive Agents / therapeutic use
• Interferon alpha-2
• Interferon-alpha / adverse effects
• Interferon-alpha / therapeutic use*
• Liver Transplantation
• Male
• Middle Aged
• Polyethylene Glycols / adverse effects
• Polyethylene Glycols / therapeutic use*
• Prospective Studies
• Recombinant Proteins
• Recurrence
• Ribavirin / adverse effects
• Ribavirin / therapeutic use*
• Severity of Illness Index
• Time Factors
• Treatment Outcome
• Viral Load